Machine learning for the prediction of blood transfusion risk during or after mitral valve surgery: a multicenter retrospective cohort study

Comprehensive Summary

This research looked into how machine learning might forecast if someone needs a red blood cell transfusion around the time of mitral valve surgery, using just pre-surgery details. Data came from 1,477 individuals across eight Chinese medical centers; various algorithms were then applied. Among them, LightGBM stood out, delivering consistent precision in training, testing, and even a limited follow-up sample. Key predictors tied to higher likelihood of transfusion involved measures like hematocrit, number of red cells, body weight, BMI, fibrinogen concentration, hemoglobin value, years lived, stature, enlargement of the heart's main pump chamber, and gender.

Outcomes and Implications

The results help spot individuals more likely to require transfusions ahead of surgery, medical teams gain time to act. Preparation includes reserving blood supplies, managing low red blood cell levels sooner, while integrating techniques that minimize bleeding when operating. Those unlikely to need donated blood avoid it - cutting exposure to potential infections and adverse reactions tied to transfusions. With these insights, patient care becomes both more precise and cautious, especially for those receiving mitral valve procedures. Limited supply meets smarter allocation through this approach driven by predictive modeling.